Employees: 3,578
Size China Isotope & Radiation (1763.HK) is a Hong Kong Health Care company (Medical Specialties) with a market value of $428M, the 783rd largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$10.82 on 18 Nov 2026.
Performance Over six months the shares fell 40.9%, against -16.2% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — lowest of 21 in its peer set.
Growth Revenue fell 5.1% over the last twelve months (peer median +4.6%); the operating margin is 13.1% (peer median 3.2%).
Valuation It trades at 6.0× forward earnings against a peer median of 17.1× (cheapest of 8).
Next results Next results expected around 31 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | n/a | HK$7.80B | HK$8.21B | HK$7.33B | HK$7.16B |
| Revenue growth | — | -5% | +12% | +2% | — |
| Gross profit | n/a | HK$3.90B | HK$3.99B | HK$3.84B | HK$4.09B |
| EBITDA | n/a | HK$1.30B | HK$1.35B | HK$1.06B | HK$1.21B |
| Net income | n/a | HK$355M | HK$441M | HK$410M | HK$456M |
| Free cash flow | n/a | -HK$53.9M | -HK$1.00B | -HK$836M | HK$425M |
| Capital expenditure | n/a | HK$615M | HK$1.12B | HK$992M | HK$670M |
| Total debt | n/a | HK$3.12B | HK$2.79B | HK$1.94B | HK$1.06B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 1763.HK | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -9.7% | -9.3% | 10th lowest of 21 |
| 6-month return | -40.9% | -16.2% | lowest of 21 |
| Distance from 52-week high | -56.7% | -40.7% | 4th lowest of 21 |
| Revenue growth (TTM) | -5.1% | +4.6% | 5th lowest of 20 |
| Operating margin | 13.1% | 3.2% | 4th highest of 20 |
| Forward P/E | 6.0× | 17.1× | cheapest of 8 |
| Net debt / EBITDA | 0.2× | -1.3× | 2nd most indebted of 4 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| China Isotope & Radiation 1763.HK | Hong Kong | $428M | -41% | -5% | 13% | 6.0× | n/a | n/a |
| Revenio REG1V.HE | Finland | $428M | -34% | +44% | 10% | 17.1× | 18.5% | +12.4% |
| Hunan Sundy Science and Technology 300515.SZ | China | $425M | -16% | +10% | 27% | 13.2× | -0.1% | +15.6% |
| Shoulder Innovations SI | United States | $432M | +39% | +55% | -54% | n/a | n/a | n/a |
| Mobia Medical MOBI | United States | $434M | +2% | +105% | -145% | n/a | n/a | n/a |
| Guangzhou Jet Bio-Filtration 688026.SS | China | $436M | +39% | +5% | 11% | 35.7× | 20.6% | +2.2% |
| Ningbo Tianyi Medical Appliance 301097.SZ | China | $418M | -22% | +46% | 8% | n/a | n/a | n/a |
| Huaren Pharmaceutical 300110.SZ | China | $440M | -16% | -3% | 6% | n/a | 5.8% | +0.3% |
| Jenscare Scientific 9877.HK | Hong Kong | $415M | -32% | +993% | -106% | n/a | n/a | n/a |
| Clarity Pharmaceuticals CU6.AX | Australia | $444M | -33% | n/a | n/a | n/a | n/a | n/a |
| Chison Medical Technologies 688358.SS | China | $406M | -27% | -1% | 19% | 19.8× | 9.6% | +5.6% |
| Shanghai Kindly Enterprises Development 603987.SS | China | $452M | -12% | 0% | 10% | n/a | -1.0% | -2.8% |
| Guangdong Shirongzhaoye 002016.SZ | China | $453M | -26% | -31% | 3% | n/a | 21.5% | -11.7% |
| Shanghai Titan Scientific 688133.SS | China | $403M | -26% | +1% | -6% | 8.4× | n/a | n/a |
| PROTEINA 468530.KS | South Korea | $460M | +5% | -59% | -1,178% | n/a | n/a | n/a |
| Beijing Leadman Biochemistry 300289.SZ | China | $460M | -9% | +46% | 1% | n/a | 36.0% | -6.9% |
| Guanhao Biotech 300238.SZ | China | $397M | -26% | -12% | 3% | n/a | n/a | n/a |
| 908 Devices MASS | United States | $396M | +36% | +14% | -33% | n/a | 41.7% | +15.9% |
| OrbusNeich Medical 6929.HK | Hong Kong | $394M | -15% | +16% | 23% | 8.4× | -17.6% | +15.4% |
| MiMedx MDXG | United States | $464M | -16% | -23% | -8% | n/a | 10.9% | +11.0% |
| Eiken Chemical 4549.T | Japan | $466M | -20% | +4% | 6% | 24.5× | n/a | n/a |